DTC Is Not Improving, Rep. Waxman Says: Viagra Ads Show “Six” Sells?
Executive Summary
The decline in advertising enforcement actions by FDA does not reflect better compliance in direct-to-consumer advertisements, House Government Reform Committee Ranking Member Henry Waxman (D-Calif.) maintains
You may also be interested in...
Overactive Bladder Ads Become Frequent; 3 DTC Spots Break In Last 2 Months
Pfizer, Johnson & Johnson and GlaxoSmithKline/ Yamanouchi have each released new direct-to-consumer TV advertisements for their overactive bladder products in the last two months as the sector has become more competitive
Overactive Bladder Ads Become Frequent; 3 DTC Spots Break In Last 2 Months
Pfizer, Johnson & Johnson and GlaxoSmithKline/ Yamanouchi have each released new direct-to-consumer TV advertisements for their overactive bladder products in the last two months as the sector has become more competitive
Rep. Waxman Challenges FDA Contact With Rx Companies On DTC Guides
Rep. Henry Waxman (D-Calif.) is asking FDA to defend its communications with pharmaceutical companies relating to the development of direct-to-consumer advertising guidances